Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 91001 | L189 | 64232-83-3 | 98% |  |
| L189 inhibits base excision repair (BER) and non-homologous end joining (NHEJ), which | ||||
| 82608 | Linagliptin | 668270-12-0 | 98% |  |
| Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM. | ||||
| 81313 | Lurasidone hydrochloride | 367514-87-2 | 98% |  |
| Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma, which | ||||
| 81001 | LRRK2-IN-1 | 1234480-84-2 | 97% |  |
| LRRK2-IN-1 is a cell-permeable, ATP competitive, potent, and selective LRRK2 inhibito | ||||
| 71801 | LY2874455 | 1254473-64-7 | 98% |  |
| 1) Sponsor: Eli Lilly and Company.2) Phase:Phase 12) LY2874455 is potent, selective, | ||||
| 52806 | LDK378 | 1032900-25-6 | 98% |  |
| LDK378(Ceritinib) is potent inhibitor against ALK with IC50 of 0.2 nM, shows 40- and | ||||
| 52733 | LDN193189 | 1062368-24-4 | 98% |  |
| LDN193189(DM 3189) is a selective BMP signaling inhibitor, inhibits the transcription | ||||
| 52707 | LDN-214117 | 1627503-67-6 | 98% | |
| LDN-214117 is a potent and selective ALK2 inhibitor with IC50 of 22 nM; > 100 fold | ||||
| 52588 | LDN-212854 | 1432597-26-6 | 98% |  |
| LDN-212854 is a potent and selectiveBMP receptorinhibitor with IC50 of 1.3 nM for ALK | ||||
| 52511 | LB-100 | 1026680-07-8 | 98% | |
| LB-100 is a small-molecular protein phosphatase 2A(PP2A)inhibitor with IC50 of 0.85 M | ||||
| 52509 | LY-364947 | 396129-53-6 | 98% |  |
| LY364947 is a potent ATP-competitive inhibitor of TGFR-I with IC50 of 59 nM, exhibits | ||||
| 51504 | LH846 | 639052-78-1 | 98% |  |
| LH846 is a selective inhibitor of CK1 (IC50 values are 290 nM, 1.3 uM and 2.5 uM for | ||||
| 52309 | LY294002 | 154447-36-6 | 98% |  |
| LY294002 is the first synthetic molecule known to inhibitPI3K//withIC50of 0.5 M/0.57 | ||||
| 52206 | LFM-A13 | 244240-24-2 | 98% |  |
| Selective Bruton's tyrosine kinase (BTK) inhibitor (IC50 = 2.5 M). Also inhibits poli | ||||
| 51703 | Luminespib ( NVP-AUY922 ; VER-52296 ) | 747412-49-3 | 98% | _747412-49-3.png) |
| NVP-AUY922 is an experimental drug candidate for the treatment of cancer. It was disc | ||||